Hence, we proved that the cytotoxic and apoptosis-inducing potency of doxorubicin, a Pgp substrate and a first line chemotherapeutic drug to treat breast cancers, has been significantly raised in co-treatments with 75 nm AgNPs in multidrug-resistant MCF-7/KCR cells. The gene discussed is PGP; the disease is breast cancer.